Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | TK2 | O00142 | 2/20 | 0.31 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TK1 | P04183 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5663554 | 0.78 | CHRM2 (0.31) | — | |
| SCHEMBL8870562 | 0.75 | KIF11 (0.53) | ESR1BLMCYP2D6HRH4KIF11 | |
| SCHEMBL8135345 | 0.73 | CHRM3 (0.35) | — | |
| Methylene Chloride SCHEMBL27870524 | 0.71 | — | — | |
| SCHEMBL6834879 | 0.71 | PDE4B (0.54) | KIF11SLC6A1SLC6A11PDE4B | |
| SCHEMBL8869561 | 0.70 | KIF11 (0.52) | HRH4KIF11TK2CYP2C9TK1 | |
| SCHEMBL28832854 | 0.70 | — | — | |
| SCHEMBL8870247 | 0.69 | KIF11 (0.50) | KIF11TK2CYP2C9TK1TBXA2R | |
| SCHEMBL1884316 | 0.69 | KIF11 (0.50) | KIF11TK2CYP2C9TK1TBXA2R | |
| SCHEMBL1884344 | 0.69 | KIF11 (0.50) | KIF11TK2CYP2C9TK1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040249152-A1 | Method for the production of cna | NANOGEN RECOGNOMICS GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249152-A1 | Method for the production of cna | RNGTT, COASY, CNOT7 | ESR1 4857/4885BLM 1533/4885CYP2D6 4457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.